Enhancing Patient Care in Inflammatory Bowel Disease
At NYU Langone Health, the Inflammatory Bowel Disease Center is making significant strides by expanding its leadership team and incorporating a distinguished colorectal surgeon. This initiative aims to elevate the standard of patient care, reinforcing the center's commitment to providing exemplary medical services.
Comprehensive Management of Inflammatory Bowel Disease
The Inflammatory Bowel Disease Center specializes in treating chronic conditions like Crohn's disease and ulcerative colitis. These conditions can lead to severe symptoms, including persistent diarrhea, abdominal discomfort, fatigue, and significant weight loss, which can adversely affect patients' quality of life and overall health.
Leadership Expansion with Esteemed Professionals
Center director David P. Hudesman, MD, proudly welcomes two new co-directors: gastroenterologist Jordan E. Axelrad, MD, MPH, and colorectal surgeon Andre da Luz Moreira, MD. Their inclusion is a clear reflection of NYU Langone's dedication to personalized care and innovative treatment strategies.
Dr. Hudesman expressed that, "Drs. Axelrad and Moreira have been valuable members of our multidisciplinary team for several years. Their expertise in the latest diagnostics and advancements in IBD will play a crucial role in guiding the center’s future. This leadership ensures that we remain frontrunners in treatment while providing our patients with cutting-edge medical therapies and minimally invasive surgical options.”
Personal Journey and Research Contributions
Dr. Jordan E. Axelrad has a unique perspective on IBD, having been diagnosed with Crohn's disease during his late teen years. His research, supported by the National Institutes of Health, addresses connections between IBD and gut microbiome health, mucosal immunology, and cancer risks. His remarkable contributions earned him the prestigious 2024 Sherman Emerging Leader Prize.
In addition, Dr. Andre da Luz Moreira, known for his personalized surgical care approach, specializes in minimally invasive and robot-assisted surgery techniques to manage a variety of colorectal conditions while aiming for long-lasting positive outcomes for his patients.
Welcoming a Distinguished Colorectal Surgeon
The center further strengthens its capabilities with the arrival of David W. Dietz, MD, a well-respected colorectal surgeon focused on complex IBD surgeries. Dr. Dietz serves as the vice chair of value and transformation in the Department of Surgery. His experience in managing intricate surgical cases will greatly enhance the center's offerings.
According to Robert Montgomery, MD, DPhil, chair of the Department of Surgery, “Dr. Dietz’s remarkable skill set and compassionate approach fit perfectly with our mission at NYU Langone. His expertise ensures that our patients receive the highest standard of surgical care tailored to their needs.”
Specialized Surgical Techniques
Dr. Dietz is proficient in advanced surgical techniques such as continent ileostomy surgery, also known as K-pouch surgery, among other complex procedures. This ground-breaking operation is performed by only a few specialized surgeons across the country. It enables patients to manage their bodily functions discreetly without the need for external appliances. Additionally, his techniques in redo ileal pouch–anal anastomosis aim to preserve bowel function effectively.
He remarked, “Understanding each patient’s unique situation and being able to restore their health and quality of life is fundamental to my practice. I am proud to be joining a team that genuinely prioritizes patient-centered care.”
NYU Langone's National Recognition for IBD Care
NYU Langone continues to receive national acclaim, consistently ranked among the top 5 hospitals for gastroenterology and GI surgery by U.S. News & World Report. The Inflammatory Bowel Disease Center’s holistic methodology incorporates cutting-edge diagnostics, medical treatments, surgical procedures, and supportive services such as nutritional and psychological counseling.
Patients visiting the Inflammatory Bowel Disease Center at NYU Langone Ambulatory Care have access to exceptional medical and surgical care tailored to their specific needs. These specialized services ensure that all patients receive comprehensive attention and support in managing their conditions.
Frequently Asked Questions
What is the focus of the Inflammatory Bowel Disease Center?
The center specializes in providing comprehensive care for individuals suffering from inflammatory bowel diseases, focusing on individualized treatment plans and advanced surgical options.
Who are the newly appointed leaders at the center?
The center has appointed Jordan E. Axelrad, MD, MPH, and Andre da Luz Moreira, MD, as co-directors, expanding its leadership team and enhancing its specialized care capabilities.
How does Dr. Dietz contribute to the center?
Dr. David W. Dietz brings extensive experience in complex IBD surgeries, further strengthening the center’s surgical offerings with specialized techniques and compassionate patient care.
What unique approaches do the new directors employ?
Both directors utilize innovative diagnostic tools and research in their strategies to ensure that patients receive individualized care that addresses their unique health challenges.
Why is NYU Langone recognized nationally?
The Inflammatory Bowel Disease Center’s commitment to excellence in patient care and the implementation of multidisciplinary strategies have earned the center national recognition.
